Skip to main content
Clinical Trials/NCT01368965
NCT01368965
Completed
Not Applicable

Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Cheek Tissue and Improvement in Jawline Definition and Submental Skin Laxity in Patients With Fitzpatrick Skin Phototypes 3 Through 6

Ulthera, Inc2 sites in 1 country54 target enrollmentMarch 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Facial Skin Laxity
Sponsor
Ulthera, Inc
Enrollment
54
Locations
2
Primary Endpoint
Change in Overall Lifting and Tightening of Treated Tissue
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This prospective, multi-center, single treatment clinical trial evaluates the clinical outcomes associated with non-invasive treatment to obtain lift and tightening of facial tissue and improve jawline definition in subjects with darker skin color utilizing the Ulthera® System to deliver focused ultrasound energy below the skin surface.

Detailed Description

The primary objective of this clinical trial is to demonstrate the effectiveness of the Ulthera® System for the non-invasive treatment to obtain overall lift and tightening of facial tissue and jawline definition improvement.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
August 2012
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 30 to 65 years.
  • Subject in good health.
  • Subjects who desire lift and tightening of cheek tissue, improvement in jawline definition and/or submental skin laxity.
  • Fitzpatrick skin phototypes of 3 through
  • Provide written informed consent and HIPAA authorization

Exclusion Criteria

  • Pregnant or lactating.
  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat on the cheek.
  • Excessive skin laxity on the lower face and neck.
  • Significant scarring in areas to be treated.
  • Significant open facial wounds or lesions.
  • Severe or cystic acne on the face.
  • Presence of a metal stent or implant in the facial area to be treated.

Outcomes

Primary Outcomes

Change in Overall Lifting and Tightening of Treated Tissue

Time Frame: 90 days post treatment

The percentage of participants assessed to have improvement in skin laxity, i.e., lifted and tightened skin in the areas treated with the Ulthera System, as determined by three masked assessors comparing pre-treatment and 90-days post-treatment photos

Secondary Outcomes

  • Patient Satisfaction Questionnaire(180 days post-treatment)
  • Global Aesthetic Improvement at 90 Days Post-treatment(90 Days post-treatment)
  • Global Aesthetic Improvement at 180 Days Post-treatment(180 days post-treatment)

Study Sites (2)

Loading locations...

Similar Trials